Author Archives: Ed Wilson

How many emergency admissions can primary care policies actually prevent? Answer: Not many.

Emergency admissions, as well as the obvious effect on the patient, family and carers, cost a lot. In 2012, they cost the NHS over £12.5 billion, so understandably there is a desire to contain these costs as they may be better spent elsewhere. A good number of these admissions will be unavoidable and the NHS …read more

Posted in Blog | Tagged , , , , , | Comments closed

NHS Health Checks: value for money?

Reports in the Guardian and Telegraph this week report on a study published in the Journal of Public Health suggesting that the NHS health checks are costing £450,000 per life saved and therefore represent very poor value for money. Unfortunately these press reports are woefully misleading, although the study itself does little to discourage such …read more

Posted in Blog | Tagged , , | Comments closed

Is an intensive treatment regimen for newly diagnosed type 2 diabetes patients cost-effective? Economic evaluation of the 5-year results of the ADDITION study.

A new paper in Diabetic Medicine reports an economic evaluation of the ADDITION study, based on the five year follow-up data.  The Anglo-Danish-Dutch study of Intensive Treatment In peOple with screeN detected diabetes (ADDITION) is a prospective randomised controlled trial of screening and intensive treatment of newly diagnosed type-2 diabetes patients. The five-year outcomes, published …read more

Posted in Blog | Tagged , , , , | Group: | Comments closed

NHS reforms: plus ça change

The King’s Fund today released the first half of its verdict on how well the coalition has done on the NHS.  The second half – looking at NHS performance since 2010 – will be released in March, but today’s report focuses on the Lansley reforms.  Their verdict?  To put it bluntly, damning.  ‘Distracting and damaging’ were …read more

Posted in Blog | Tagged , | Group: | Comments closed

CCHSR is recruiting Health Economists

We are expanding our team of health economists and wish to recruit two health economists, one at the University of Cambridge and one at RAND Europe.

Posted in News | Tagged , | Group: | Comments closed

The economics won’t go away: NHS Cancer Drugs Fund to consider cost-effectiveness

This week, NHS England published its revised process for operation of the cancer drugs fund.  Of particular interest is the requirement to take into account both costs and effects of treatments. NICE was set up in 1999 with the remit of considering the value for money, or cost-effectiveness of new and existing treatments. It is …read more

Posted in Blog | Tagged , , , | Comments closed

NICE and Roche at loggerheads (again)

  NICE has today (8th August 2014) announced that it cannot recommend Roche’s latest breast cancer drug, Kadcyla (a combination of trastuzumab and emtansine) for routine use on the NHS because it is too expensive and hence not cost-effective.  The draft ‘no’ was actually published in May, but there has been a press release issued today …read more

Posted in Blog, News | Tagged , | Group: | Comments closed

European Conference on Health Economics – Dublin, July 2014

Last week saw the European Conference on Health Economics (ECHE) hosted by Trinity College Dublin.  CCHSR’s Ed Wilson was there. International conferences are always a great opportunity to find out what your colleagues are up to in different corners of the world.  ECHE was no exception.  The venue was Trinity College Dublin, home to the beautifully …read more

Posted in Blog | Tagged , , , | Group: | Comments closed

Keeping Cochrane reviews up-to-date

The Cochrane Collaboration is an organisation that conducts systematic reviews of healthcare interventions.  The idea is that they are updated periodically (every 2 years) so that they provide the best evidence on what works and what doesn’t. After 21 years of existence, the Cochrane Library now holds over 6000 reviews by some 20,000 volunteer authors.  …read more

Posted in Blog | Tagged , , | Group: | Comments closed

Reducing Waste in Research

In 2009, Chalmers and Glasziou published a study claiming that up to 80% of research is wasted. They further identified various points in the research process at which the waste occurs, including failures to ask the ‘right’ questions, use of inappropriate study designs and methods, selective publication of the results and failure to adequately report …read more

Posted in Blog | Tagged , | Group: | Comments closed
  • The Cambridge Centre for Health Services Research (CCHSR) is a thriving collaboration between the University of Cambridge and RAND Europe. We aim to inform health policy and practice by conducting research and evaluation studies of organisation and delivery of healthcare, including safety, effectiveness, efficiency and patient experience.